Stem Cell Therapy Company Hypes Preliminary Results

A biotech company has been accused of releasing preliminary and misleading information about a clinical trial. The company, Osiris Therapeutics, is the manufacturer of a cultured mesenchymal stem cell therapy called Prochymal, which is being studied in a phase 2, placebo-controlled study in post-MI patients. Earlier this week Osiris issued a press release [...]

More:

Stem Cell Therapy Company Hypes Preliminary Results

Related Posts

Comments are closed.